Ex vivo evaluation of a novel polyiodinated compound for early detection of atherosclerosis.
Atherosclerosis is a primary cause of heart disease and stroke; it is the underlying cause of about 50% of all deaths in Western countries. It is known that early detection of atherosclerotic lesions would significantly reduce the risk of mortality. The objective of this study was to develop a radioimaging method for early detection of atherosclerotic plaques. A novel polyiodinated cholesterol analog, cholesteryl 1,3-diiopanoate glyceryl ether (C2I, patent pending), was synthesized and radiolabeled with 125I. 125I-C2I was incorporated into acetylated low-density lipoprotein (AcLDL), which is considered to be an atherosclerotic plaque-seeking carrier. 125I-C2I was also prepared as a chylomicron-like emulsion. Transgenic mice deficient in apoE and low-density lipoprotein receptors (LDLR), known as apoE/LDLR double knockout, were used as an animal model of early atherosclerosis. 125I-C2I/AcLDL or 125I-C2I emulsion was injected into the apoE/LDLR knockout mice via the tail vein, and the mice were killed humanely 24 h after injection. Various tissues including aorta were removed and radioactivity was determined. The aorta samples were also imaged to determine the accumulation of radioactivity from C2I. The images were compared to the atherosclerotic lesions revealed by histological studies. It was found that both 125I-C2I/AcLDL and 125I-C2I emulsion resulted in accumulation of radioactivity at the site of early atherosclerotic lesions, and they therefore may be useful for early detection of atherosclerosis.
Kang
Zhili
Z
School of Pharmacy, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
Scott
Thomas M
TM
Wesolowski
Carl
C
Feng
Liping
L
Wang
Jinguo
J
Wang
Lili
L
Liu
Hu
H
D000818:Animals; D001011:Aorta / Q000000981:diagnostic imaging* / Q000378:metabolism* / Q000473:pathology; D001161:Arteriosclerosis / Q000000981:diagnostic imaging* / Q000378:metabolism* / Q000473:pathology; D001345:Autoradiography / Q000379:methods*; D002784:Cholesterol / Q000031:analogs & derivatives / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D007553:Isotope Labeling / Q000379:methods*; D051379:Mice; D018345:Mice, Knockout; D009928:Organ Specificity; D011874:Radiometry / Q000379:methods; D011877:Radionuclide Imaging; D012016:Reference Values; D014915:Whole-Body Counting
C478781:cholesteryl 1,3-diiopanoate glyceryl ether; D002784:Cholesterol